Kaleorid

Potassium Chloride, the active ingredient in Kaleorid, is an electrolyte supplement presented as an oral formulation for restoring potassium balance in patients with low serum potassium. It is used to treat hypokalemia and related potassium deficiency conditions in adult and pediatric populations where indicated. GNH USA supplies Kaleorid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaleorid is an oral potassium chloride product that addresses electrolyte disturbances, particularly low potassium levels. It is employed in the following clinical situations: - Hypokalemia: restores normal serum potassium concentrations and prevents cardiac complications. - Potassium deficiency: supplies essential potassium ions to support muscular and neuronal function. - Cardiac arrhythmia associated with low potassium: helps stabilize cardiac electrical activity.

Kaleorid may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the abdomen. - Diarrhea: loose stools occurring after dosing. - Taste disturbance: metallic or salty taste perception. - Mild hyperkalemia: slight elevation of serum potassium without symptoms.

Serious or Rare Side Effects: - Severe hyperkalemia: marked increase in serum potassium leading to cardiac arrhythmia. - Muscle weakness or paralysis: due to excessive potassium levels. - Allergic reaction: rash, itching, or swelling. - Anaphylaxis: rare, potentially life‑threatening hypersensitivity. - Severe skin eruption: such as Stevens‑Johnson syndrome.

Before prescribing Kaleorid, clinicians should consider several safety measures. - Monitor serum potassium: check levels before initiation and regularly during therapy. - Adjust dose in renal impairment: reduce dosage or increase monitoring frequency. - Caution in cardiac disease: evaluate risk of arrhythmias. - Avoid in existing hyperkalemia: contraindicated when potassium is already elevated. - Use with caution in the elderly: monitor for fluid and electrolyte shifts. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Kaleorid can interact with other medications that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - ARBs (angiotensin II receptor blockers): potentiate potassium elevation.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of digoxin toxicity with high potassium. - NSAIDs: may reduce renal potassium excretion. - Lithium: concurrent use can alter lithium levels. - Certain antibiotics (e.g., trimethoprim): may increase potassium retention.